abstract |
The method of treating a leukotriene-mediated disease which is treatable by inhibition of 5-lipoxygenase includes administering a therapeutically effective amount of 2,4,6-triiodophenol, or a pharmaceutically acceptable salt or solvate thereof, for 5-lipoxygenase inhibition, together with an adequate amount of pharmaceutically acceptable excipients, diluents or carriers to the patient suffering from the disease. The diseases treated advantageously include, among others, herpes and gastrointestinal, respiratory, skin and/or ocular inflammatory diseases. |